Biochips

Biochips can save lives in Myocardial Infarction patients

Published in Lab Business Week, August 12th, 2007

Time is of the essence in myocardial infarction (MI) patients, as treatment for an MI has to be commenced within the first 12 hours of the acute event to be effective. Biochip multi-markers have been shown to diagnose more MIs within 12 hours of chest pain onset than current diagnostic practice.

These findings came from a study in a Dublin hospital where over 3000 blood samples were collected from 1100 patients over a 3-year period. The markers were assessed simultaneously using the revolutionary biochip array technology. Miniaturisation of multiple test sites on the biochip surface keeps sample and reagent volume to a minimum and automation of the test on a stand-alone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-08-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry